Sabitlenmiş Tweet

WinSanTor, Inc. is developing a proprietary first-in-class therapy to prevent and reverse nerve damage. Sign up for our newsletter to receive the latest news on our drug, clinical trials and more: winsantor.com/join/
#winsantor #clinicaltrials #peripheralneuropathy

English













